WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting

Mergers & Acquisitions

Open PDF
  • Advise on Hundreds of M&A Deals Annually

    In 2025, Wilson Sonsini advised on more than 150 announced and/or completed M&A deals with an aggregate disclosed value of $100 billion. 

  • Comprehensive Scope of Transactions Experience

    Wilson Sonsini M&A attorneys advise companies on both the buy and sell sides of all manner of transactions, ranging from multibillion-dollar public company transactions to small "tuck-in" acquisitions, and everything in between. Our attorneys have deep experience with a variety of deals, including strategic mergers and business combinations, complex cross-border transactions, SPACs and reverse mergers, business and asset acquisitions and carve-outs, growth equity investments, joint ventures, and spin-offs and other business dispositions.

A Leading M&A Firm

Wilson Sonsini consistently is ranked among the leading M&A advisors in the country based on the number of announced and/or completed transactions by such authorities as Bloomberg, Thomson Reuters, LSEG, and Mergermarket.

Comprehensive Scope of Transactions Experience

Wilson Sonsini counsels on the full range of M&A transactions involving domestic and foreign technology, life sciences, and other enterprises at all stages of development. We have advised clients on:

  • Transformative transactions where complex governance matters, debt financings, antitrust, intellectual property, and other matters intersect 
  • Acquisition programs, scaling legal teams and processes to handle both smaller and larger transactions on a cost-efficient basis 
  • Creative and flexible structures for complex transactions

A Global and Interdisciplinary Team

Our team of over 500 corporate and M&A attorneys around the world often serve as the coordinating interface with in-house counsel for a multidisciplinary Wilson Sonsini team because of their experience in areas of importance to transactions, including corporate governance; corporate securities; IP; privacy; executive compensation and employee benefits; tax; and real estate. We also have an elite merger clearance team comprised of antitrust and national security attorneys and advise on regulatory matters inherently involved in completing transactions, including antitrust clearance and foreign direct investment approvals in the United States and across the globe. In addition, we have established relationships with leading law firms in international markets that are not in proximity to our own global office locations.

Aligned with Client M&A Strategies

We have become a trusted advisor to companies at all growth stages because of the breadth of our M&A transactional experience combined with our “client-first” approach. For every engagement, we align with our client’s M&A strategy to gain a full understanding of their business priorities, objectives, and internal operations, as well as the unique elements of the transaction. Our clients also rely on our unparalleled ability to work collaboratively with all key constituencies in a deal, including boards of directors, founders and control shareholders, management teams, and investors. 

Representative Transactions

Select M&A transactions in which the firm has participated include representing:

Milestone Transactions

  • Brex in its $5.15 billion acquisition by Capital One
  • Jony Ive and LoveFrom in the $6.5 billion acquisition of io Products by OpenAI 
  • Scale AI in its $14.35 billion investment from Meta 
  • Bungie in its $3.6 billion acquisition by Sony
  • DoorDash in its $8.1 billion acquisition of Wolt 
  • Medallia in its $6.4 billion acquisition by Thoma Bravo 
  • Twitter in its $44 billion acquisition by Elon Musk 
  • CA Technologies in its $18.9 billion acquisition by Broadcom 
  • Microchip in its $10.3 billion acquisition of Microsemi 
  • MuleSoft in its $6.5 billion acquisition by Salesforce
  • Linear Technology in its $14.8 billion acquisition by Analog Devices 
  • Yahoo in its $4.5 billion acquisition by Verizon 
  • LinkedIn in its $26.2 billion acquisition by Microsoft 
  • NetSuite in its $9.3 billion acquisition by Oracle
  • Altera in its $16.7 billion acquisition by Intel 
  • Pharmacyclics in its $21 billion acquisition by AbbVie
  • McAfee in its $7.7 billion acquisition by Intel 
  • Sun Microsystems in its $8.3 billion acquisition by Oracle
  • Genentech in its $46.8 billion acquisition by Roche 
  • Google in its $3.1 billion acquisition of DoubleClick 
  • YouTube in its $1.65 billion acquisition by Google 
  • Pixar in its $7.4 billion acquisition by Disney 

Recent Public Company M&A Transactions

  • Arcellx in its pending $7.8 billion acquisition by Gilead
  • Soleno Therapeutics in its pending $2.9 billion acquisition by Neurocrine
  • Armada Acquisition Corp. II in its pending $1 billion business combination with Evernorth Holdings
  • Udemy in its pending $2.5 billion combination with Coursera
  • Marvell in its $3.25 acquisition of Celestial AI
  • Lumentum in its strategic partnership and related $2 billion equity investment from NVIDIA
  • Couchbase in its $1.5 billion acquisition by Haveli Investments
  • Transcarent in its $861.8 million acquisition of Accolade
  • Infinera in its $2.4 billion acquisition by Nokia
  • HashiCorp in its $6.4 billion acquisition by IBM 
  • Rover in its $2.4 billion acquisition by Blackstone
  • Hawaiian Airlines in its $1.9 billion acquisition by Alaska Airlines 
  • Silk Road Medical in its $1.3 billion acquisition by Boston Scientific 
  • VIZIO in its $2.3 billion acquisition by Walmart
  • Amphastar in its $1.2 billion acquisition of BAQSIMI
  • Thorne HealthTech in its $680 million acquisition by L Catterton 
  • ForgeRock in its $2.3 billion acquisition by Thoma Bravo 
  • Momentive in its $1.5 billion acquisition by Symphony Technology Group 
  • Sumo Logic in its $1.7 billion acquisition by Francisco Partners 
  • KnowBe4 in its $4.6 billion acquisition by Vista Equity Partners
  • Mandiant in its $5.4 billion acquisition by Alphabet
  • Poly in its $3.3 billion acquisition by HP Inc. 
  • Zynga in its $12.7 billion acquisition by Take-Two
  • Sierra Oncology in its $1.9 billion acquisition by GSK 
  • Talend in its $2.4 billion acquisition by Thoma Bravo

Other Recent M&A Transactions

  • Special committee of the board in Globalstar’s pending $11.57 billion acquisition by Amazon
  • Excellergy in its pending $2 billion acquisition by Novartis
  • Plus in its pending $1.2 billion business combination with Churchill IX
  • Centerview as financial advisor to Qorvo in its pending $22 billion acquisition by Skyworks
  • Chronosphere in its $3.35 billion acquisition by Palo Alto Networks
  • Morgan Stanley as financial advisor to Confluent in its $11 billion acquisition by IBM
  • OneStream in its $6.4 billion acquisition by Hg
  • Ventyx Biosciences in its $1.2 billion acquisition by Eli Lilly
  • Major shareholders of HistoSonics in its $2.25 billion majority stake acquisition
  • Fivetran in its pending merger with dbt Labs 
  • Grammarly in its acquisition of Superhuman Labs 
  • Clio in its $1 billion acquisition of vLex
  • Ampere Computing in its $6.5 billion acquisition by SoftBank Group
  • Xero in its $3 billion acquisition of Melio
  • Kodiak in its $3.3 billion Business Combination with Ares Acquisition Corporation 
  • Taiho Pharmaceutical in its $1.1 billion acquisition of Araris Biotech
  • Marvell in Infineon's $2.5 billion acquisition of its Automotive Ethernet Business 
  • Windsurf in its acquisition by Cognition AI
  • Anduril in its acquisition of the IVAS Program from Microsoft 
  • Divvy Homes (portfolio and platform) in its $1 billion acquisition by Maymont Homes
  • Grammarly in its acquisition of Coda Project 
  • Pismo in its $1 billion acquisition by Visa
  • Kerecis in its $1.3 billion acquisition by Coloplast 
  • DTx Pharma in its $1.1 billion acquisition by Novartis 
  • Morgan Stanley as financial advisor to Qualtrics in its $11.2 billion acquisition by Silver Lake Management 
  • Qatalyst Partners as financial advisor to Citrix in its $16.7 billion acquisition by Vista Equity Partners and Elliott Management 
Overview

A Leading M&A Firm

Wilson Sonsini consistently is ranked among the leading M&A advisors in the country based on the number of announced and/or completed transactions by such authorities as Bloomberg, Thomson Reuters, LSEG, and Mergermarket.

Comprehensive Scope of Transactions Experience

Wilson Sonsini counsels on the full range of M&A transactions involving domestic and foreign technology, life sciences, and other enterprises at all stages of development. We have advised clients on:

  • Transformative transactions where complex governance matters, debt financings, antitrust, intellectual property, and other matters intersect 
  • Acquisition programs, scaling legal teams and processes to handle both smaller and larger transactions on a cost-efficient basis 
  • Creative and flexible structures for complex transactions

A Global and Interdisciplinary Team

Our team of over 500 corporate and M&A attorneys around the world often serve as the coordinating interface with in-house counsel for a multidisciplinary Wilson Sonsini team because of their experience in areas of importance to transactions, including corporate governance; corporate securities; IP; privacy; executive compensation and employee benefits; tax; and real estate. We also have an elite merger clearance team comprised of antitrust and national security attorneys and advise on regulatory matters inherently involved in completing transactions, including antitrust clearance and foreign direct investment approvals in the United States and across the globe. In addition, we have established relationships with leading law firms in international markets that are not in proximity to our own global office locations.

Aligned with Client M&A Strategies

We have become a trusted advisor to companies at all growth stages because of the breadth of our M&A transactional experience combined with our “client-first” approach. For every engagement, we align with our client’s M&A strategy to gain a full understanding of their business priorities, objectives, and internal operations, as well as the unique elements of the transaction. Our clients also rely on our unparalleled ability to work collaboratively with all key constituencies in a deal, including boards of directors, founders and control shareholders, management teams, and investors. 

Representative Transactions

Select M&A transactions in which the firm has participated include representing:

Milestone Transactions

  • Brex in its $5.15 billion acquisition by Capital One
  • Jony Ive and LoveFrom in the $6.5 billion acquisition of io Products by OpenAI 
  • Scale AI in its $14.35 billion investment from Meta 
  • Bungie in its $3.6 billion acquisition by Sony
  • DoorDash in its $8.1 billion acquisition of Wolt 
  • Medallia in its $6.4 billion acquisition by Thoma Bravo 
  • Twitter in its $44 billion acquisition by Elon Musk 
  • CA Technologies in its $18.9 billion acquisition by Broadcom 
  • Microchip in its $10.3 billion acquisition of Microsemi 
  • MuleSoft in its $6.5 billion acquisition by Salesforce
  • Linear Technology in its $14.8 billion acquisition by Analog Devices 
  • Yahoo in its $4.5 billion acquisition by Verizon 
  • LinkedIn in its $26.2 billion acquisition by Microsoft 
  • NetSuite in its $9.3 billion acquisition by Oracle
  • Altera in its $16.7 billion acquisition by Intel 
  • Pharmacyclics in its $21 billion acquisition by AbbVie
  • McAfee in its $7.7 billion acquisition by Intel 
  • Sun Microsystems in its $8.3 billion acquisition by Oracle
  • Genentech in its $46.8 billion acquisition by Roche 
  • Google in its $3.1 billion acquisition of DoubleClick 
  • YouTube in its $1.65 billion acquisition by Google 
  • Pixar in its $7.4 billion acquisition by Disney 

Recent Public Company M&A Transactions

  • Arcellx in its pending $7.8 billion acquisition by Gilead
  • Soleno Therapeutics in its pending $2.9 billion acquisition by Neurocrine
  • Armada Acquisition Corp. II in its pending $1 billion business combination with Evernorth Holdings
  • Udemy in its pending $2.5 billion combination with Coursera
  • Marvell in its $3.25 acquisition of Celestial AI
  • Lumentum in its strategic partnership and related $2 billion equity investment from NVIDIA
  • Couchbase in its $1.5 billion acquisition by Haveli Investments
  • Transcarent in its $861.8 million acquisition of Accolade
  • Infinera in its $2.4 billion acquisition by Nokia
  • HashiCorp in its $6.4 billion acquisition by IBM 
  • Rover in its $2.4 billion acquisition by Blackstone
  • Hawaiian Airlines in its $1.9 billion acquisition by Alaska Airlines 
  • Silk Road Medical in its $1.3 billion acquisition by Boston Scientific 
  • VIZIO in its $2.3 billion acquisition by Walmart
  • Amphastar in its $1.2 billion acquisition of BAQSIMI
  • Thorne HealthTech in its $680 million acquisition by L Catterton 
  • ForgeRock in its $2.3 billion acquisition by Thoma Bravo 
  • Momentive in its $1.5 billion acquisition by Symphony Technology Group 
  • Sumo Logic in its $1.7 billion acquisition by Francisco Partners 
  • KnowBe4 in its $4.6 billion acquisition by Vista Equity Partners
  • Mandiant in its $5.4 billion acquisition by Alphabet
  • Poly in its $3.3 billion acquisition by HP Inc. 
  • Zynga in its $12.7 billion acquisition by Take-Two
  • Sierra Oncology in its $1.9 billion acquisition by GSK 
  • Talend in its $2.4 billion acquisition by Thoma Bravo

Other Recent M&A Transactions

  • Special committee of the board in Globalstar’s pending $11.57 billion acquisition by Amazon
  • Excellergy in its pending $2 billion acquisition by Novartis
  • Plus in its pending $1.2 billion business combination with Churchill IX
  • Centerview as financial advisor to Qorvo in its pending $22 billion acquisition by Skyworks
  • Chronosphere in its $3.35 billion acquisition by Palo Alto Networks
  • Morgan Stanley as financial advisor to Confluent in its $11 billion acquisition by IBM
  • OneStream in its $6.4 billion acquisition by Hg
  • Ventyx Biosciences in its $1.2 billion acquisition by Eli Lilly
  • Major shareholders of HistoSonics in its $2.25 billion majority stake acquisition
  • Fivetran in its pending merger with dbt Labs 
  • Grammarly in its acquisition of Superhuman Labs 
  • Clio in its $1 billion acquisition of vLex
  • Ampere Computing in its $6.5 billion acquisition by SoftBank Group
  • Xero in its $3 billion acquisition of Melio
  • Kodiak in its $3.3 billion Business Combination with Ares Acquisition Corporation 
  • Taiho Pharmaceutical in its $1.1 billion acquisition of Araris Biotech
  • Marvell in Infineon's $2.5 billion acquisition of its Automotive Ethernet Business 
  • Windsurf in its acquisition by Cognition AI
  • Anduril in its acquisition of the IVAS Program from Microsoft 
  • Divvy Homes (portfolio and platform) in its $1 billion acquisition by Maymont Homes
  • Grammarly in its acquisition of Coda Project 
  • Pismo in its $1 billion acquisition by Visa
  • Kerecis in its $1.3 billion acquisition by Coloplast 
  • DTx Pharma in its $1.1 billion acquisition by Novartis 
  • Morgan Stanley as financial advisor to Qualtrics in its $11.2 billion acquisition by Silver Lake Management 
  • Qatalyst Partners as financial advisor to Citrix in its $16.7 billion acquisition by Vista Equity Partners and Elliott Management 
Client Highlights
Wilson Sonsini Advises Cognite, Major Shareholders on $3.1 Billion Sale to Schneider Electric
On June 30, 2026, Aker ASA (Aker) and the other shareholders of Cognite announced that they have entered into an agreement to sell 100 percent of the shares in Cognite Holding B.V. (Cognite) to Schneider Electric based on an enterprise value of US$3.1 billion. Wilson Sonsini Goodrich & Rosati’s cross-border tech M&A team advised Cognite and its major shareholders, including Aker, TCV, and Accel, on the transaction.
Client Highlights
Wilson Sonsini Advises Rocket Lab on $8 Billion Acquisition of Iridium
On June 29, 2026, Rocket Lab Corporation, a global leader in launch and space systems, and Iridium Communications, a leading provider of global voice, data and positioning, navigation, and timing satellite services, announced they have entered into a definitive agreement under which Rocket Lab will acquire Iridium. Rocket Lab will acquire all the outstanding shares of Iridium common stock for $54 per share in a cash and stock transaction. This represents an enterprise value for Iridium of approximately $8 billion. Wilson Sonsini Goodrich & Rosati is advising Rocket Lab on the transaction.
Client Highlights
Wilson Sonsini Advises Saturnus Bio on Strategic Collaboration with Merck KGaA, Darmstadt, Germany
On June 23, 2026, Merck KGaA, Darmstadt, Germany, a leading global science and technology company, announced a strategic collaboration with Versant Ventures to launch Saturnus Bio, a next-generation precision cardiology company that utilizes targeted gene modulation to address rare mono-genetic cardiomyopathies with significant unmet need. Wilson Sonsini Goodrich & Rosati advised Saturnus Bio on the transaction.

The research-stage partnership entails a build-to-buy deal structure, including an upfront payment of $50 million from Merck KGaA, Darmstadt, Germany to fund Saturnus Bio’s research activities, securing a minority equity stake in the company, as well as additional success-based preclinical milestones, supporting the development of novel drug candidates for genetic cardiomyopathy patients. Merck KGaA, Darmstadt, Germany has exclusive rights to acquire Saturnus Bio for a pre-determined option payment, in addition to success-based earnouts.

The Wilson Sonsini team that advised Saturnus Bio on the transaction includes:
Client Highlights
Firm Advises QCi on Acquisition of NHanced
On June 22, 2026, Quantum Computing Inc. (QCi), an innovative, quantum optics and integrated photonics technology company, announced the completion of acquiring NHanced Semiconductors for a combination of cash and QCi stock valued at $73.1 million, subject to customary adjustments, and up to an additional $72.0 million if certain performance targets are achieved. Wilson Sonsini Goodrich & Rosati advised QCi on the transaction.
Client Highlights
Firm Advises 4E Therapeutics on Acquisition by Eli Lilly
On June 16, 2026, 4E Therapeutics, an Austin-based neuroscience company developing next-generation treatments for chronic pain, announced that it has been acquired by Eli Lilly and Company. Wilson Sonsini Goodrich & Rosati advised 4E Therapeutics on the transaction.
Bylined Articles
Law360 Article: “7 Key Questions About SEC’s Faster Tender Offer Path”
Wilson Sonsini attorneys Rob Ishii, Doug Schnell, Remi Korenblit, Tamara Brightwell, and Michael Anthony authored a recent Law360 article titled "7 Key Questions About SEC’s Faster Tender Offer Path." The piece examines the recent order issued by the SEC to shorten the minimum offering period on certain equity tender offers. The authors walk through seven key questions covering eligibility requirements, timeline implications, private company applicability, and strategic considerations—noting that while the shortened period offers meaningful efficiency gains, parties must carefully weigh trade-offs, including reduced time for boards to consider topping proposals and potential sequencing issues with go-shop periods.
View All
Insights
Client Highlights
Wilson Sonsini Advises Cognite, Major Shareholders on $3.1 Billion Sale to Schneider Electric
On June 30, 2026, Aker ASA (Aker) and the other shareholders of Cognite announced that they have entered into an agreement to sell 100 percent of the shares in Cognite Holding B.V. (Cognite) to Schneider Electric based on an enterprise value of US$3.1 billion. Wilson Sonsini Goodrich & Rosati’s cross-border tech M&A team advised Cognite and its major shareholders, including Aker, TCV, and Accel, on the transaction.
Client Highlights
Wilson Sonsini Advises Rocket Lab on $8 Billion Acquisition of Iridium
On June 29, 2026, Rocket Lab Corporation, a global leader in launch and space systems, and Iridium Communications, a leading provider of global voice, data and positioning, navigation, and timing satellite services, announced they have entered into a definitive agreement under which Rocket Lab will acquire Iridium. Rocket Lab will acquire all the outstanding shares of Iridium common stock for $54 per share in a cash and stock transaction. This represents an enterprise value for Iridium of approximately $8 billion. Wilson Sonsini Goodrich & Rosati is advising Rocket Lab on the transaction.
Client Highlights
Wilson Sonsini Advises Saturnus Bio on Strategic Collaboration with Merck KGaA, Darmstadt, Germany
On June 23, 2026, Merck KGaA, Darmstadt, Germany, a leading global science and technology company, announced a strategic collaboration with Versant Ventures to launch Saturnus Bio, a next-generation precision cardiology company that utilizes targeted gene modulation to address rare mono-genetic cardiomyopathies with significant unmet need. Wilson Sonsini Goodrich & Rosati advised Saturnus Bio on the transaction.

The research-stage partnership entails a build-to-buy deal structure, including an upfront payment of $50 million from Merck KGaA, Darmstadt, Germany to fund Saturnus Bio’s research activities, securing a minority equity stake in the company, as well as additional success-based preclinical milestones, supporting the development of novel drug candidates for genetic cardiomyopathy patients. Merck KGaA, Darmstadt, Germany has exclusive rights to acquire Saturnus Bio for a pre-determined option payment, in addition to success-based earnouts.

The Wilson Sonsini team that advised Saturnus Bio on the transaction includes:
Client Highlights
Firm Advises QCi on Acquisition of NHanced
On June 22, 2026, Quantum Computing Inc. (QCi), an innovative, quantum optics and integrated photonics technology company, announced the completion of acquiring NHanced Semiconductors for a combination of cash and QCi stock valued at $73.1 million, subject to customary adjustments, and up to an additional $72.0 million if certain performance targets are achieved. Wilson Sonsini Goodrich & Rosati advised QCi on the transaction.
Client Highlights
Firm Advises 4E Therapeutics on Acquisition by Eli Lilly
On June 16, 2026, 4E Therapeutics, an Austin-based neuroscience company developing next-generation treatments for chronic pain, announced that it has been acquired by Eli Lilly and Company. Wilson Sonsini Goodrich & Rosati advised 4E Therapeutics on the transaction.
Bylined Articles
Law360 Article: “7 Key Questions About SEC’s Faster Tender Offer Path”
Wilson Sonsini attorneys Rob Ishii, Doug Schnell, Remi Korenblit, Tamara Brightwell, and Michael Anthony authored a recent Law360 article titled "7 Key Questions About SEC’s Faster Tender Offer Path." The piece examines the recent order issued by the SEC to shorten the minimum offering period on certain equity tender offers. The authors walk through seven key questions covering eligibility requirements, timeline implications, private company applicability, and strategic considerations—noting that while the shortened period offers meaningful efficiency gains, parties must carefully weigh trade-offs, including reduced time for boards to consider topping proposals and potential sequencing issues with go-shop periods.
View All
Affiliated Programs
The L Suite Webinar: Inside the Deal - How GCs and Their Teams Actually Run M&A
On June 16, Wilson Sonsini and The L Suite will co-host a webinar, “Inside the Deal: How GCs and Their Teams Actually Run M&A.” The virtual panel will explore how general counsel and their deputies operate during live transactions.
Affiliated Programs
Diligent Next Gen Board Leaders' Summit 2026
Wilson Sonsini is thrilled to sponsor Diligent’s Next Gen Board Leaders’ Summit in New York, a premier biannual event for new public company directors. This invite-only event features insightful panel discussions around the challenges and opportunities the boardroom presents and member-only networking opportunities.
Affiliated Programs
The L Suite TechGC Nexus 2026
Wilson Sonsini is a proud sponsor of The L Suite TechGC Nexus 2026, a marquee annual gathering of general counsel and chief legal officers from high-growth, venture-backed and public technology companies and venture funds. Attendees will have opportunities to exchange candid insights on how to help drive their companies’ growth in a new era of technology and risk.
Affiliated Programs
The L Suite 2026 Deputy GC Summit
Wilson Sonsini will sponsor The L Suite’s 2026 Deputy GC Summit, an exclusive event designed for deputy general counsel and senior in-house counsel who sit at the center of the company’s most complex decisions. Attendees will have practical, peer-driven conversations that cover how they lead, partner, and stay ahead of risk. This year’s theme is “Owning the Unknown: Designing Your Work, Your Team, Your Future.”
Affiliated Programs
The L Suite Webinar: Buying the Team, Not the Company - Legal and Structuring Considerations in Acquihires
Wilson Sonsini will co-host The L Suite’s “Buying the Team, Not the Company: Legal and Structuring Considerations in Acquihires” webinar on March 31, 2026.
Affiliated Programs
Growth Unlocked: A Roadmap to Transaction Readiness
Wilson Sonsini and Connor Group will co-host “Growth Unlocked” in Utah, an exclusive program designed for senior executives navigating or actively exploring IPO and M&A opportunities.
View All
Events
Affiliated Programs
The L Suite Webinar: Inside the Deal - How GCs and Their Teams Actually Run M&A
On June 16, Wilson Sonsini and The L Suite will co-host a webinar, “Inside the Deal: How GCs and Their Teams Actually Run M&A.” The virtual panel will explore how general counsel and their deputies operate during live transactions.
Affiliated Programs
Diligent Next Gen Board Leaders' Summit 2026
Wilson Sonsini is thrilled to sponsor Diligent’s Next Gen Board Leaders’ Summit in New York, a premier biannual event for new public company directors. This invite-only event features insightful panel discussions around the challenges and opportunities the boardroom presents and member-only networking opportunities.
Affiliated Programs
The L Suite TechGC Nexus 2026
Wilson Sonsini is a proud sponsor of The L Suite TechGC Nexus 2026, a marquee annual gathering of general counsel and chief legal officers from high-growth, venture-backed and public technology companies and venture funds. Attendees will have opportunities to exchange candid insights on how to help drive their companies’ growth in a new era of technology and risk.
Affiliated Programs
The L Suite 2026 Deputy GC Summit
Wilson Sonsini will sponsor The L Suite’s 2026 Deputy GC Summit, an exclusive event designed for deputy general counsel and senior in-house counsel who sit at the center of the company’s most complex decisions. Attendees will have practical, peer-driven conversations that cover how they lead, partner, and stay ahead of risk. This year’s theme is “Owning the Unknown: Designing Your Work, Your Team, Your Future.”
Affiliated Programs
The L Suite Webinar: Buying the Team, Not the Company - Legal and Structuring Considerations in Acquihires
Wilson Sonsini will co-host The L Suite’s “Buying the Team, Not the Company: Legal and Structuring Considerations in Acquihires” webinar on March 31, 2026.
Affiliated Programs
Growth Unlocked: A Roadmap to Transaction Readiness
Wilson Sonsini and Connor Group will co-host “Growth Unlocked” in Utah, an exclusive program designed for senior executives navigating or actively exploring IPO and M&A opportunities.
View All
Jason Breen
Partner
Los Angeles
Jason Breen is a partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati, where he represents public and private companies at all stages of growth in M&A transactions, primarily working with clients in the life sciences and technology industries. Jason also represents venture capital, growth equity, and private equity funds and focuses on other strategic transactions, including divestitures, joint ventures, and financings.
  • Mergers & Acquisitions
View Profile
Todd Cleary
Partner
San Francisco
Todd represents companies, investors and other parties in private equity transactions.
  • Mergers & Acquisitions
View Profile
Jack Hamilton
Partner
New York
Jack Hamilton (they/them) is a partner in Wilson Sonsini Goodrich & Rosati’s mergers and acquisitions practice. They represent public and private companies in a wide variety of M&A transactions, including mergers, stock purchases, asset acquisitions, tender and exchange offers, and other strategic transactions. In addition, Jack counsels both private and publicly held companies on general corporate governance and disclosure matters.
  • Corporate
View Profile
Mark P. Holloway
Partner
Washington, D.C.
Mark counsels public and private tech and life sciences companies through all stages of growth and focuses on strategic transactions.
  • Corporate
View Profile
Robert T. Ishii
Partner
San Francisco
Rob represents technology and life sciences clients in M&A and other transformative deals.
  • Mergers & Acquisitions
View Profile
Brian Keyes
Partner
Seattle
Brian represents technology and life sciences clients in M&A and other transformative deals.
  • Mergers & Acquisitions
View Profile
Remi P. Korenblit
Partner
Seattle
Remi Korenblit is a partner at Wilson Sonsini Goodrich & Rosati, where his practice focuses on mergers and acquisitions, corporate governance, financing transactions, and other corporate and securities law matters. His transaction experience includes mergers, business combinations, asset and stock purchases, divestitures, carve-outs and spin-off transactions, private equity and venture financing transactions, joint ventures, and other strategic transactions for both public and private companies. He also advises clients on corporate governance matters, shareholder activism, takeover defense, recapitalizations and restructurings, and other special situations. Remi has represented U.S. and international clients in a variety of sectors, including software and technology, telecommunication, media, banking and finance, industrial, manufacturing, pharmaceutical, energy, and retail industries.
  • Corporate
View Profile
Martin W. Korman
Partner
Palo Alto
Marty represents technology and life sciences clients in M&A and other transformative deals.
  • Corporate
View Profile
Kathy H. Ku
Partner
Century City
Katherine H. Ku is a corporate and securities partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati. She represents both public and private companies and private equity funds in a variety of corporate transactions, including mergers and acquisitions, equity and debt financings, and joint ventures. Kathy also advises clients on corporate governance and securities compliance matters. In addition, she has experience representing special committees of boards of directors in connection with buy-out matters.
  • Mergers & Acquisitions
View Profile
Ethan P. Lutske
Partner
San Francisco
Ethan represents clients in mergers and acquisitions, as well as other strategic transactions.
  • Mergers & Acquisitions
View Profile
View All
People
Jason Breen
Partner
Los Angeles
Jason Breen is a partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati, where he represents public and private companies at all stages of growth in M&A transactions, primarily working with clients in the life sciences and technology industries. Jason also represents venture capital, growth equity, and private equity funds and focuses on other strategic transactions, including divestitures, joint ventures, and financings.
  • Mergers & Acquisitions
View Profile
Todd Cleary
Partner
San Francisco
Todd represents companies, investors and other parties in private equity transactions.
  • Mergers & Acquisitions
View Profile
Jack Hamilton
Partner
New York
Jack Hamilton (they/them) is a partner in Wilson Sonsini Goodrich & Rosati’s mergers and acquisitions practice. They represent public and private companies in a wide variety of M&A transactions, including mergers, stock purchases, asset acquisitions, tender and exchange offers, and other strategic transactions. In addition, Jack counsels both private and publicly held companies on general corporate governance and disclosure matters.
  • Corporate
View Profile
Mark P. Holloway
Partner
Washington, D.C.
Mark counsels public and private tech and life sciences companies through all stages of growth and focuses on strategic transactions.
  • Corporate
View Profile
Robert T. Ishii
Partner
San Francisco
Rob represents technology and life sciences clients in M&A and other transformative deals.
  • Mergers & Acquisitions
View Profile
Brian Keyes
Partner
Seattle
Brian represents technology and life sciences clients in M&A and other transformative deals.
  • Mergers & Acquisitions
View Profile
Remi P. Korenblit
Partner
Seattle
Remi Korenblit is a partner at Wilson Sonsini Goodrich & Rosati, where his practice focuses on mergers and acquisitions, corporate governance, financing transactions, and other corporate and securities law matters. His transaction experience includes mergers, business combinations, asset and stock purchases, divestitures, carve-outs and spin-off transactions, private equity and venture financing transactions, joint ventures, and other strategic transactions for both public and private companies. He also advises clients on corporate governance matters, shareholder activism, takeover defense, recapitalizations and restructurings, and other special situations. Remi has represented U.S. and international clients in a variety of sectors, including software and technology, telecommunication, media, banking and finance, industrial, manufacturing, pharmaceutical, energy, and retail industries.
  • Corporate
View Profile
Martin W. Korman
Partner
Palo Alto
Marty represents technology and life sciences clients in M&A and other transformative deals.
  • Corporate
View Profile
Kathy H. Ku
Partner
Century City
Katherine H. Ku is a corporate and securities partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati. She represents both public and private companies and private equity funds in a variety of corporate transactions, including mergers and acquisitions, equity and debt financings, and joint ventures. Kathy also advises clients on corporate governance and securities compliance matters. In addition, she has experience representing special committees of boards of directors in connection with buy-out matters.
  • Mergers & Acquisitions
View Profile
Ethan P. Lutske
Partner
San Francisco
Ethan represents clients in mergers and acquisitions, as well as other strategic transactions.
  • Mergers & Acquisitions
View Profile
View All
Related Practices
  • Antitrust Merger Clearance
  • Corporate Governance
  • Corporate Life Sciences
  • Employee Benefits and Compensation
  • Intellectual Property
  • Public Company Representation
  • Special Purpose Acquisition Companies (SPACs)
  • Tax
  • Technology Transactions
Recent Insights
Client Highlights
Wilson Sonsini Advises Cognite, Major Shareholders on $3.1 Billion Sale to Schneider Electric
On June 30, 2026, Aker ASA (Aker) and the other shareholders of Cognite announced that they have entered into an agreement to sell 100 percent of the shares in Cognite Holding B.V. (Cognite) to Schneider Electric based on an enterprise value of US$3.1 billion. Wilson Sonsini Goodrich & Rosati’s cross-border tech M&A team advised Cognite and its major shareholders, including Aker, TCV, and Accel, on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Rocket Lab on $8 Billion Acquisition of Iridium
On June 29, 2026, Rocket Lab Corporation, a global leader in launch and space systems, and Iridium Communications, a leading provider of global voice, data and positioning, navigation, and timing satellite services, announced they have entered into a definitive agreement under which Rocket Lab will acquire Iridium. Rocket Lab will acquire all the outstanding shares of Iridium common stock for $54 per share in a cash and stock transaction. This represents an enterprise value for Iridium of approximately $8 billion. Wilson Sonsini Goodrich & Rosati is advising Rocket Lab on the transaction.
Learn More
View All
Recent Events
Affiliated Programs
The L Suite Webinar: Inside the Deal - How GCs and Their Teams Actually Run M&A
On June 16, Wilson Sonsini and The L Suite will co-host a webinar, “Inside the Deal: How GCs and Their Teams Actually Run M&A.” The virtual panel will explore how general counsel and their deputies operate during live transactions.
Learn More
Affiliated Programs
Diligent Next Gen Board Leaders' Summit 2026
Wilson Sonsini is thrilled to sponsor Diligent’s Next Gen Board Leaders’ Summit in New York, a premier biannual event for new public company directors. This invite-only event features insightful panel discussions around the challenges and opportunities the boardroom presents and member-only networking opportunities.
Learn More
View All
Key Contacts
Robert T. Ishii
Partner
San Francisco
Rob represents technology and life sciences clients in M&A and other transformative deals.
  • Mergers & Acquisitions
View Profile
Rich Mullen
Partner
San Francisco
Rich is a strategic advisor who counsels boards of directors and management teams on M&A and other transformative transactions.
  • Mergers & Acquisitions
View Profile
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.